AIM ImmunoTech Inc. (AIMI)
OTCMKTS
· Delayed Price · Currency is USD
0.0400
+0.0100 (33.33%)
Apr 17, 2025, 4:00 PM EDT
AIM ImmunoTech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 1.7 | 5.44 | 27.05 | 32.09 | 38.5 | Upgrade
|
| Short-Term Investments | 2.28 | 7.63 | 7.14 | 16.18 | 0.5 | Upgrade
|
| Cash & Short-Term Investments | 3.98 | 13.07 | 34.19 | 48.27 | 39 | Upgrade
|
| Cash Growth | -69.57% | -61.77% | -29.17% | 23.76% | 344.31% | Upgrade
|
| Accounts Receivable | - | - | - | - | 0.03 | Upgrade
|
| Other Receivables | - | 1.18 | 1.68 | 1.64 | 1.09 | Upgrade
|
| Receivables | - | 1.18 | 1.68 | 1.64 | 1.12 | Upgrade
|
| Prepaid Expenses | 0.2 | 0.3 | 0.46 | 0.3 | 0.18 | Upgrade
|
| Total Current Assets | 4.18 | 14.56 | 36.32 | 50.21 | 40.31 | Upgrade
|
| Property, Plant & Equipment | 0.73 | 0.82 | 1.02 | 4.2 | 6.65 | Upgrade
|
| Long-Term Investments | - | - | - | - | 15.38 | Upgrade
|
| Other Intangible Assets | 2.59 | 2.31 | 1.94 | 1.97 | 1.5 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 1.6 | 1.12 | - | - | Upgrade
|
| Other Long-Term Assets | 1.11 | 0.08 | 0.08 | 1.32 | 0.75 | Upgrade
|
| Total Assets | 8.61 | 19.38 | 40.49 | 57.7 | 64.58 | Upgrade
|
| Accounts Payable | 6.38 | 6.44 | 0.38 | 0.2 | 0.38 | Upgrade
|
| Accrued Expenses | 0.61 | 1.99 | 0.81 | 0.44 | 0.44 | Upgrade
|
| Current Portion of Long-Term Debt | 2.31 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 0.24 | 0.22 | 0.18 | 0.04 | 0.28 | Upgrade
|
| Total Current Liabilities | 9.54 | 8.65 | 1.36 | 0.67 | 1.1 | Upgrade
|
| Long-Term Leases | 0.4 | 0.5 | 0.66 | 0.11 | 2.01 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0.04 | 0.18 | Upgrade
|
| Total Liabilities | 9.93 | 9.15 | 2.02 | 0.82 | 3.29 | Upgrade
|
| Common Stock | 0.07 | 0.05 | 0.05 | 0.05 | 0.04 | Upgrade
|
| Additional Paid-In Capital | 425.44 | 419 | 418.27 | 417.22 | 402.54 | Upgrade
|
| Retained Earnings | -426.83 | -409.51 | -380.55 | -361.1 | -341.97 | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | -0.05 | Upgrade
|
| Total Common Equity | -1.32 | 9.55 | 37.77 | 56.16 | 60.56 | Upgrade
|
| Shareholders' Equity | -1.32 | 10.23 | 38.47 | 56.88 | 61.29 | Upgrade
|
| Total Liabilities & Equity | 8.61 | 19.38 | 40.49 | 57.7 | 64.58 | Upgrade
|
| Total Debt | 2.94 | 0.72 | 0.84 | 0.15 | 2.29 | Upgrade
|
| Net Cash (Debt) | 1.04 | 12.35 | 33.35 | 48.12 | 52.09 | Upgrade
|
| Net Cash Growth | -91.61% | -62.97% | -30.69% | -7.63% | 2072.35% | Upgrade
|
| Net Cash Per Share | 0.02 | 0.25 | 0.69 | 1.02 | 1.64 | Upgrade
|
| Filing Date Shares Outstanding | 72.29 | 49.9 | 48.41 | 47.99 | 47.82 | Upgrade
|
| Total Common Shares Outstanding | 65.53 | 49.1 | 48.08 | 47.99 | 42.15 | Upgrade
|
| Working Capital | -5.36 | 5.9 | 34.96 | 49.54 | 39.21 | Upgrade
|
| Book Value Per Share | -0.02 | 0.19 | 0.79 | 1.17 | 1.44 | Upgrade
|
| Tangible Book Value | -3.92 | 7.23 | 35.83 | 54.19 | 59.06 | Upgrade
|
| Tangible Book Value Per Share | -0.06 | 0.15 | 0.75 | 1.13 | 1.40 | Upgrade
|
| Land | - | - | - | 3.9 | 10.55 | Upgrade
|
| Machinery | 1.47 | 1.45 | 2.23 | 2.35 | 5.14 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.